AI Insight
This article is a correction notice published by the PLOS ONE editorial staff regarding a previously published study on the role of intracellular cyclic guanosine monophosphate (cGMP) signaling in thyroid cancer cell death. The correction addresses an error or inaccuracy in the original publication, which investigated whether increases in intracellular cGMP levels contribute to cell death mechanisms in thyroid cancer cells. The original study's central finding was that cGMP elevation is not a mediating factor in thyroid cancer cell death pathways.
Why it matters
Understanding the signaling mechanisms that govern thyroid cancer cell death is relevant to the development of targeted therapies, and corrections to published research help maintain the accuracy of the scientific record that informs such development.
by The PLOS One Staff
Source: Correction: Intracellular cGMP increase is not involved in thyroid cancer cell death